Deciphering epigenetically-regulated pathways to improve targeted therapy for invasion and metastasis in head and neck cancer

破译表观遗传调控途径以改善头颈癌侵袭和转移的靶向治疗

基本信息

  • 批准号:
    10650527
  • 负责人:
  • 金额:
    $ 60.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-15 至 2027-12-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cause of cancer-related mortality, with most deaths attributable to metastasis and treatment failure. Unfortunately, our understanding of the pathways that underlie invasion and metastasis is incomplete, but some hints were uncovered by our recent single cell sequencing analyses which revealed that many HNSCC tumors contained cells that were neither fully epithelial nor fully mesenchymal, but were in a unique, hybrid epithelial-mesenchymal (hybrid-EM) state. The presence of hybrid-EM cells was more predictive of poor response than smoking history, and functional studies established hybrid-EM as a key driver of invasion and metastasis. Together, these observations establish hybrid-EM as a central pathway in HNSCC progression. However, hybrid-EM marker proteins are not druggable, so it remains challenging to therapeutically target this state. Cell states like hybrid-EM are regulated by a variety of mechanisms, but super-enhancers, in particular, have been identified as essential for maintaining cell identity. We therefore targeted super-enhancers in HNSCC using the BET inhibitor JQ1 and observed a reduction in HNSCC invasion of ~2-fold and a suppression of hybrid-EM. This result was encouraging, but effect size was modest due to the indirect and non-specific mode of action of JQ1. We hypothesized that if we could elucidate genes regulated by super-enhancers in HNSCC, we could identify molecular pathways that are more directly and specifically involved with invasion and metastasis and uncover more potent targets. Our initial experiments found that super-enhancers regulate cholesterol biosynthesis genes in hybrid-EM cells and that their knockdown (KD) robustly disrupts hybrid-EM phenotypes, with a >2000-fold and >8000-fold reduction in invasion upon KD of two mevalonate synthesis genes. Importantly, the protein products of many of the cholesterol genes we identified can be inhibited by commercially available small molecules. Indeed, we found that statins, which inhibit cholesterol biosynthesis, potently inhibit invasion (>10-fold reduction). These data provide strong support for our original hypothesis. We now propose to use CRISPRi to systematically investigate the role of cholesterol metabolism in invasion in HNSCC using sophisticated in vitro and in vivo models (Aim 1). In Aim 2, we will evaluate 9 small molecule inhibitors of cholesterol biosynthesis in cell lines, patient-derived organoids (PDOs), and in vivo pre-clinical models. Finally, in Aim 3, we will identify the full regulatory network of super-enhancers that control hybrid-EM, specifically focusing on Brd2-4 which are inhibited by JQ1. For these experiments, we will use single cell approaches to account for tumor heterogeneity and thereby uncover additional pathways beyond cholesterol biosynthesis that direct invasion and metastasis. Together, these experiments will provide critical insights into how super-enhancers regulate hybrid-EM, while exploring the possibility that by targeting the super-enhancer-regulated cholesterol biosynthesis pathway using existing FDA-approved drugs, we could circumvent a length drug development process and move quickly into human trials.
项目摘要 头颈部鳞状细胞癌(HNSCC)是癌症相关死亡的第六大原因, 大多数死亡可归因于转移和治疗失败。不幸的是,我们对这些途径的理解 在侵袭和转移的基础上的基因是不完整的,但我们最近的单细胞研究发现了一些线索。 测序分析显示,许多HNSCC肿瘤含有既不是完全上皮细胞, 也不完全是间充质的,而是处于独特的上皮-间充质混合(混合-EM)状态。存在 杂交EM细胞的表达比吸烟史更能预测不良反应,功能研究建立了 杂交-EM作为侵袭和转移的关键驱动因素。总之,这些观察将混合EM确立为 HNSCC进展的中枢通路。然而,杂交EM标记蛋白是不可药物化的,所以它仍然存在。 很难治疗这种状态像混合EM这样的细胞状态是由多种 机制,但特别是超级增强子,已被确定为维持细胞身份所必需的。 因此,我们使用BET抑制剂JQ 1靶向HNSCC中的超级增强子,并观察到HNSCC中的增强子减少。 HNSCC侵袭约2倍,并抑制混合EM。这一结果是令人鼓舞的,但效果大小是 由于JQ 1的间接和非特异性作用模式,因此不明显。我们假设如果我们能阐明 在HNSCC中,通过超级增强子调控的基因,我们可以确定更直接的分子途径, 并特别涉及侵袭和转移,并发现更有效的靶点。我们最初的实验 发现超级增强子调节混合EM细胞中的胆固醇生物合成基因, (KD)稳健地破坏杂交EM表型,在KD时侵袭减少>2000倍和>8000倍 两个甲羟戊酸合成基因重要的是,我们体内的许多胆固醇基因的蛋白质产物, 已鉴定的可通过市售小分子抑制。事实上,我们发现,抑制 胆固醇生物合成,有效地抑制侵袭(>10倍减少)。这些数据为我们提供了有力的支持。 原始假设我们现在建议使用CRISPRi系统地研究胆固醇的作用 使用复杂的体外和体内模型研究HNSCC侵袭中的代谢(目的1)。在目标2中,我们将 评价细胞系、患者源性类器官(PDO)中胆固醇生物合成的9种小分子抑制剂, 和体内临床前模型。最后,在目标3中,我们将确定超级增强子的完整调控网络 控制混合EM,特别是关注被JQ 1抑制的Brd 2 -4。对于这些实验,我们 将使用单细胞方法来解释肿瘤的异质性,从而发现其他途径 除了胆固醇的生物合成外,它还直接影响肿瘤的侵袭和转移。这些实验将提供 对超级增强子如何调节混合EM的重要见解,同时探索通过靶向 超级增强子调节胆固醇生物合成途径使用现有FDA批准的药物,我们可以 绕过漫长的药物开发过程,迅速进入人体试验。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robi D Mitra其他文献

Robi D Mitra的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robi D Mitra', 18)}}的其他基金

An inducible molecular memory system to unravel the mechanisms of drug resistance in head and neck cancer
诱导性分子记忆系统揭示头颈癌的耐药机制
  • 批准号:
    10523122
  • 财政年份:
    2021
  • 资助金额:
    $ 60.8万
  • 项目类别:
An inducible molecular memory system to unravel the mechanisms of drug resistance in head and neck cancer
诱导性分子记忆系统揭示头颈癌的耐药机制
  • 批准号:
    10353122
  • 财政年份:
    2021
  • 资助金额:
    $ 60.8万
  • 项目类别:
COOPERATIVITY AND COLLECTIVE BINDING IN TRANSCRIPTION FACTOR-DNA INTERACTIONS
转录因子-DNA 相互作用中的合作性和集体结合
  • 批准号:
    10155502
  • 财政年份:
    2018
  • 资助金额:
    $ 60.8万
  • 项目类别:
AN INDUCIBLE MOLECULAR MEMORY SYSTEM TO RECORD TRANSIENT STATES OF CNS CELLS
记录中枢神经系统细胞瞬态的可诱导分子记忆系统
  • 批准号:
    9301354
  • 财政年份:
    2015
  • 资助金额:
    $ 60.8万
  • 项目类别:
AN INDUCIBLE MOLECULAR MEMORY SYSTEM TO RECORD TRANSIENT STATES OF CNS CELLS
记录中枢神经系统细胞瞬态的可诱导分子记忆系统
  • 批准号:
    9145785
  • 财政年份:
    2015
  • 资助金额:
    $ 60.8万
  • 项目类别:
Expanding Opportunities in Genomic Research for Underrepresented Students
为代表性不足的学生扩大基因组研究的机会
  • 批准号:
    10531218
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
DISSECTING NEURAL CELL FATE SPECIFICATION USING TRANSPOSON CALLING CARDS
使用转座子调用卡剖析神经细胞命运规范
  • 批准号:
    9096273
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
DISSECTING NEURAL CELL FATE SPECIFICATION USING TRANSPOSON CALLING CARDS
使用转座子调用卡剖析神经细胞命运规范
  • 批准号:
    8371952
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
Expanding Opportunities in Genomic Research for Underrepresented Students
为代表性不足的学生扩大基因组研究的机会
  • 批准号:
    10088843
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:
Expanding Opportunities in Genomic Research for Underrepresented Students
为代表性不足的学生扩大基因组研究的机会
  • 批准号:
    10314052
  • 财政年份:
    2012
  • 资助金额:
    $ 60.8万
  • 项目类别:

相似国自然基金

帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
  • 批准号:
    31672538
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 批准年份:
    2013
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
  • 批准号:
    81172529
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
  • 批准号:
    81070952
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
  • 批准号:
    30672361
  • 批准年份:
    2006
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目

相似海外基金

Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321481
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321480
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Continuing Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
  • 批准号:
    2317664
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Standard Grant
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
  • 批准号:
    EP/X039420/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
  • 批准号:
    EP/Y029542/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Fellowship
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
  • 批准号:
    DP240103289
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Discovery Projects
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
  • 批准号:
    2419915
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
  • 批准号:
    MR/Y013131/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
  • 批准号:
    2347997
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
  • 批准号:
    DP240103141
  • 财政年份:
    2024
  • 资助金额:
    $ 60.8万
  • 项目类别:
    Discovery Projects
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了